Skip to main content

GenomeDx Decipher GRID Tumor RNA Expression Profile Expansion

GenomeDx Biosciences has launched an expansion of its GRID Tumor RNA Expression Profile, a report generated for prostate tumors profiled with a Decipher Prostate Cancer Classifier test. The profile expansion features new markers and genomic signatures characterizing specific genomic attributes of the patients' prostate cancer, the company said. Profiles generated using the Classifier test are for research use only and will bed added to the company's cloud-based genomic data sharing and collaborative research platform, Decipher GRID, which contains over 27,000 tumor profiles and growing.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.